Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Medtronic's therapy for urinary incontinence recommended for approval by FDA panel

Aug. 8, 1997

Synsorb Biotech begins phase III trial for Synsorb Pk

July 25, 1997

FK-143: promising new BPH therapy

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

July 10, 1997

Natural products for the treatment of BPH

July 9, 1997

Agents for BPH claimed by Merck & Co.

July 8, 1997

Hemodialyzer efficacy established in patients

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Shire acquires distribution rights for Urispas from Recordati

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...